Singapore’s healthcare sector welcomed a significant new listing on 8 July 2026 with the debut of Foundation Healthcare on the SGX Mainboard. Backed by Temasek-linked SeaTown Holdings, the company raised gross proceeds of $242 million, including commitments from 10 cornerstone investors, at an initial public offering (IPO) price of $0.76 per share.
Despite strong demand, which saw the IPO 3.8 times subscribed, the stock closed 7.9% below its offer price on its first day of trading. Still, the scale and growth ambitions of Foundation Healthcare (SGX: FHH) make it one of the most noteworthy listings of the year.
#1 Singapore’s Largest Multi-Specialty Private Healthcare Platform
Foundation Healthcare has developed the country’s largest multi-speciality private healthcare network, with 108 medical specialists across 16 specialities and operates 74 specialist clinics.
Beyond clinics, it runs four medical centres: two day surgery centres in Novena and Orchard, a radiology and imaging centre, and a fertility centre.
The listing proceeds is expected to fund the acquisition of more specialist practices and medical centres in Singapore, with day surgery centres being the company’s focus moving forward. According to CEO Liaw Yit Ming, day surgery centres require about 4 months and $8 million to build, making it more scalable than building a new hospital.
#2 An Experienced Management Team With Deep Industry Expertise
The team behind Foundation Healthcare draws from decades of experience among a group of healthcare and business leaders.
CEO Liaw Yit Ming was formerly the Head of Strategic Planning and M&A at IHH Healthcare Bhd, one of the world’s largest healthcare groups.
COO Dr Lee Hong Huei was CEO of several hospitals, including Gleneagles, Mount Elizabeth Orchard and Mount Elizabeth Novena, before becoming Head, Southeast Asia for the Parkway Pantai hospital network.
CCO Choy Shook Yee was COO of Mount Elizabeth Novena and CEO of Parkway East Hospital before becoming Chief Officer, AIA Health Services Malaysia.
#3 Rapid Financial Growth
The company has demonstrated impressive growth in recent years. Revenue nearly doubled from $112.4 million in 2023 to $231.2 million in 2025, while net profit rose from $7.3 million to $41.2 million over the same period.
Despite being net profitable, there are no plans to pay dividends on profits generated in FY2026 and FY2027. This is because any profits generated will be utilised to fund and reinvest in their growth strategy.
#4 Forward-Looking Expansion Strategy
Foundation Healthcare’s growth strategy is two-pronged. First, it aims to recruit more specialists in high-demand sub-specialities to drive organic growth. Second, it plans to acquire reputable specialist practices to expand its footprint.
The company is also investing in medical centres, particularly day surgery and diagnostic facilities, to capture outpatient demand.
Technology plays a role too, with its proprietary technology platform, AVA, designed to connect patients, payors, and providers.
Read Also: 7 Things To Know About UI Boustead REIT, Singapore’s First Mainboard Listing For 2026
#5 Addressing Rising Medical Inflation In Singapore And Beyond
Foundation Healthcare highlights that Singapore’s healthcare system is facing rising costs due to an ageing population, higher demand for specialist care, and expensive hospital-based treatments.
Its model aims to shift more procedures away from hospitals into outpatient centres and specialist clinics, where costs are significantly lower. By offering day surgery, diagnostic imaging, and fertility services outside of hospital settings, patients can access care at reduced prices without compromising quality. This outpatient focus is designed to make healthcare more affordable and accessible.
#6 Reducing System-Wide Costs For The Industry
The company also positions itself as a cost-saver for the broader healthcare ecosystem. Hospital infrastructure is expensive to build and maintain, and inpatient care drives up insurance claims and government subsidies.
Foundation Healthcare’s multi-speciality platform enables insurers and payors to manage costs more efficiently, as treatments delivered in outpatient centres are less expensive than hospital stays.
By consolidating specialists into a single network, the company can streamline operations, reduce duplication, and negotiate better terms with suppliers and insurers, ultimately lowering costs across the system.
#7 Muted Market Debut Performance
Despite strong demand, Foundation Healthcare’s shares closed at $0.70 on its Wednesday debut, down 7.9% from the IPO price of $0.76. It is currently trading at $0.74. This is, unfortunately, part of a larger year-long trend in which many SGX IPOs fall below their IPO price post-debut.
Nonetheless, Foundation Healthcare remains the largest healthcare services IPO in SGX since IHH Healthcare Bhd in 2012, as well as the largest non-REIT corporate IPO to date this year.
Top Image Credit: Foundation Healthcare
Read Also: 7 Things To Know About JustCo, A GIC-Backed Co-Working Operator Listed On SGX
Bonds and Fixed Income
Singapore Treasury Bills (T-bills): What Is Cut-Off Yield, Median Yield, And Average Yield
Bonds and Fixed Income
Singapore Treasury Bills (T-bills): What Is Cut-Off Yield, Median Yield, And Average Yield
